210 related articles for article (PubMed ID: 26748931)
21. Plasmodium falciparum erythrocytic stage parasites require the putative autophagy protein PfAtg7 for normal growth.
Walker DM; Mahfooz N; Kemme KA; Patel VC; Spangler M; Drew ME
PLoS One; 2013; 8(6):e67047. PubMed ID: 23825614
[TBL] [Abstract][Full Text] [Related]
22. A class of tricyclic compounds blocking malaria parasite oocyst development and transmission.
Eastman RT; Pattaradilokrat S; Raj DK; Dixit S; Deng B; Miura K; Yuan J; Tanaka TQ; Johnson RL; Jiang H; Huang R; Williamson KC; Lambert LE; Long C; Austin CP; Wu Y; Su XZ
Antimicrob Agents Chemother; 2013 Jan; 57(1):425-35. PubMed ID: 23129054
[TBL] [Abstract][Full Text] [Related]
23. Artificial Intelligence Applied to the Rapid Identification of New Antimalarial Candidates with Dual-Stage Activity.
Lima MNN; Borba JVB; Cassiano GC; Mottin M; Mendonça SS; Silva AC; Tomaz KCP; Calit J; Bargieri DY; Costa FTM; Andrade CH
ChemMedChem; 2021 Apr; 16(7):1093-1103. PubMed ID: 33247522
[TBL] [Abstract][Full Text] [Related]
24. Identification of Novel Plasmodium falciparum Hexokinase Inhibitors with Antiparasitic Activity.
Davis MI; Patrick SL; Blanding WM; Dwivedi V; Suryadi J; Golden JE; Coussens NP; Lee OW; Shen M; Boxer MB; Hall MD; Sharlow ER; Drew ME; Morris JC
Antimicrob Agents Chemother; 2016 Oct; 60(10):6023-33. PubMed ID: 27458230
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological evaluation of benzhydryl-based antiplasmodial agents possessing Plasmodium falciparum chloroquine resistance transporter (PfCRT) inhibitory activity.
Relitti N; Federico S; Pozzetti L; Butini S; Lamponi S; Taramelli D; D'Alessandro S; Martin RE; Shafik SH; Summers RL; Babij SK; Habluetzel A; Tapanelli S; Caldelari R; Gemma S; Campiani G
Eur J Med Chem; 2021 Apr; 215():113227. PubMed ID: 33601312
[TBL] [Abstract][Full Text] [Related]
26. In Silico screening on the three-dimensional model of the Plasmodium vivax SUB1 protease leads to the validation of a novel anti-parasite compound.
Bouillon A; Giganti D; Benedet C; Gorgette O; Pêtres S; Crublet E; Girard-Blanc C; Witkowski B; Ménard D; Nilges M; Mercereau-Puijalon O; Stoven V; Barale JC
J Biol Chem; 2013 Jun; 288(25):18561-73. PubMed ID: 23653352
[TBL] [Abstract][Full Text] [Related]
27. A Novel Fluorescence Resonance Energy Transfer-Based Screen in High-Throughput Format To Identify Inhibitors of Malarial and Human Glucose Transporters.
Kraft TE; Heitmeier MR; Putanko M; Edwards RL; Ilagan MX; Payne MA; Autry JM; Thomas DD; Odom AR; Hruz PW
Antimicrob Agents Chemother; 2016 Dec; 60(12):7407-7414. PubMed ID: 27736766
[TBL] [Abstract][Full Text] [Related]
28. Interrogating a hexokinase-selected small-molecule library for inhibitors of Plasmodium falciparum hexokinase.
Harris MT; Walker DM; Drew ME; Mitchell WG; Dao K; Schroeder CE; Flaherty DP; Weiner WS; Golden JE; Morris JC
Antimicrob Agents Chemother; 2013 Aug; 57(8):3731-7. PubMed ID: 23716053
[TBL] [Abstract][Full Text] [Related]
29. Disrupting malaria parasite AMA1-RON2 interaction with a small molecule prevents erythrocyte invasion.
Srinivasan P; Yasgar A; Luci DK; Beatty WL; Hu X; Andersen J; Narum DL; Moch JK; Sun H; Haynes JD; Maloney DJ; Jadhav A; Simeonov A; Miller LH
Nat Commun; 2013; 4():2261. PubMed ID: 23907321
[TBL] [Abstract][Full Text] [Related]
30. Analysing the essential proteins set of Plasmodium falciparum PF3D7 for novel drug targets identification against malaria.
Ali F; Wali H; Jan S; Zia A; Aslam M; Ahmad I; Afridi SG; Shams S; Khan A
Malar J; 2021 Aug; 20(1):335. PubMed ID: 34344361
[TBL] [Abstract][Full Text] [Related]
31. Screening and In Vitro Evaluation of Potential Plasmodium falciparum Leucyl Aminopeptidase Inhibitors.
Chaudhary M; Singh V; Anvikar AR; Sahi S
Curr Comput Aided Drug Des; 2016; 12(4):282-293. PubMed ID: 27449897
[TBL] [Abstract][Full Text] [Related]
32. Gene expression signatures and small-molecule compounds link a protein kinase to Plasmodium falciparum motility.
Kato N; Sakata T; Breton G; Le Roch KG; Nagle A; Andersen C; Bursulaya B; Henson K; Johnson J; Kumar KA; Marr F; Mason D; McNamara C; Plouffe D; Ramachandran V; Spooner M; Tuntland T; Zhou Y; Peters EC; Chatterjee A; Schultz PG; Ward GE; Gray N; Harper J; Winzeler EA
Nat Chem Biol; 2008 Jun; 4(6):347-56. PubMed ID: 18454143
[TBL] [Abstract][Full Text] [Related]
33. Plasmodium falciparum ATG8 implicated in both autophagy and apicoplast formation.
Tomlins AM; Ben-Rached F; Williams RA; Proto WR; Coppens I; Ruch U; Gilberger TW; Coombs GH; Mottram JC; Müller S; Langsley G
Autophagy; 2013 Oct; 9(10):1540-52. PubMed ID: 24025672
[TBL] [Abstract][Full Text] [Related]
34. Discovery of covalent inhibitors of glyceraldehyde-3-phosphate dehydrogenase, a target for the treatment of malaria.
Bruno S; Pinto A; Paredi G; Tamborini L; De Micheli C; La Pietra V; Marinelli L; Novellino E; Conti P; Mozzarelli A
J Med Chem; 2014 Sep; 57(17):7465-71. PubMed ID: 25137375
[TBL] [Abstract][Full Text] [Related]
35. Yeast-based high-throughput screen identifies Plasmodium falciparum equilibrative nucleoside transporter 1 inhibitors that kill malaria parasites.
Frame IJ; Deniskin R; Rinderspacher A; Katz F; Deng SX; Moir RD; Adjalley SH; Coburn-Flynn O; Fidock DA; Willis IM; Landry DW; Akabas MH
ACS Chem Biol; 2015 Mar; 10(3):775-83. PubMed ID: 25602169
[TBL] [Abstract][Full Text] [Related]
36. Exploring dual inhibitory role of febrifugine analogues against Plasmodium utilizing structure-based virtual screening and molecular dynamic simulation.
Pandey RK; Narula A; Naskar M; Srivastava S; Verma P; Malik R; Shah P; Prajapati VK
J Biomol Struct Dyn; 2017 Mar; 35(4):791-804. PubMed ID: 26984239
[TBL] [Abstract][Full Text] [Related]
37. Computational and biophysical approaches to protein-protein interaction inhibition of Plasmodium falciparum AMA1/RON2 complex.
Pihan E; Delgadillo RF; Tonkin ML; Pugnière M; Lebrun M; Boulanger MJ; Douguet D
J Comput Aided Mol Des; 2015 Jun; 29(6):525-39. PubMed ID: 25822046
[TBL] [Abstract][Full Text] [Related]
38. Identification of new promising Plasmodium falciparum superoxide dismutase allosteric inhibitors through hierarchical pharmacophore-based virtual screening and molecular dynamics.
Araujo JSC; de Souza BC; Costa Junior DB; Oliveira LM; Santana IB; Duarte AA; Lacerda PS; Dos Santos Junior MC; Leite FHA
J Mol Model; 2018 Jul; 24(8):220. PubMed ID: 30056475
[TBL] [Abstract][Full Text] [Related]
39. In silico screening for Plasmodium falciparum enoyl-ACP reductase inhibitors.
Lindert S; Tallorin L; Nguyen QG; Burkart MD; McCammon JA
J Comput Aided Mol Des; 2015 Jan; 29(1):79-87. PubMed ID: 25344312
[TBL] [Abstract][Full Text] [Related]
40. Identification via a Parallel Hit Progression Strategy of Improved Small Molecule Inhibitors of the Malaria Purine Uptake Transporter that Inhibit
Sosa Y; Deniskin R; Frame IJ; Steiginga MS; Bandyopadhyay D; Graybill TL; Kallal LA; Ouellette MT; Pope AJ; Widdowson KL; Young RJ; Akabas MH
ACS Infect Dis; 2019 Oct; 5(10):1738-1753. PubMed ID: 31373203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
